Seeing Is Believing
with an average price target of $7.53. This is a potential upside of $7.53 (0%) from yesterday's end of day stock price of $0.
Clarus Therapeutics Holdings's activity chart (see below) currently has 3 price targets and 8 ratings on display.
Most recent stock forecast was given by SERGE BELANGER from NEEDHAM on 23-Aug-2022. First documented stock forecast 21-Sep-2021.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
2 years 3 months 6 days ago
(23-Aug-2022)
0/1 (0%)
$8.35 (228.77%)
Hold
$13
2 years 3 months 7 days ago
(22-Aug-2022)
0/1 (0%)
$8.7 (202.33%)
Buy
$10
2 years 6 months 12 days ago
(17-May-2022)
0/1 (0%)
$4.78 (91.57%)
Buy
$12
2 years 7 months 18 days ago
(11-Apr-2022)
0/1 (0%)
$3.91 (48.33%)
Buy
$20
2 years 7 months 18 days ago
(11-Apr-2022)
0/1 (0%)
$11.91 (147.22%)
What is CRXT (Clarus Therapeutics Holdings) average time for price targets to be met?
Which analyst has the current highest performing score on CRXT (Clarus Therapeutics Holdings) with a proven track record?
Which analyst has the current lower performing score on CRXT (Clarus Therapeutics Holdings) with a proven track record?
Which analyst has the most public recommendations on CRXT (Clarus Therapeutics Holdings)?
Which analyst is the currently most bullish on CRXT (Clarus Therapeutics Holdings)?
Which analyst is the currently most reserved on CRXT (Clarus Therapeutics Holdings)?